Literature DB >> 3871101

Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes.

H T Petrie, L W Klassen, H D Kay.   

Abstract

Peripheral blood granulocytes from normal healthy donors were found to reproducibly inhibit the cytolytic effector function of specifically sensitized cytotoxic T lymphocytes in vitro when co-incubated with these effector cells and target cells in 8 hr 51Cr release assays. Inhibition required intact granulocytes, was proportional to the number of granulocytes present, and was independent of granulocyte adherence, phagocytic function, and viability. Equivalent numbers of enriched normal or leukemic peripheral T lymphocytes did not cause inhibition of 51Cr release, and preincubation of granulocytes with effectors did not significantly alter viability or cytotoxic function. Because granulocytes can inhibit natural killer cell function in vitro, these data indicate that granulocytes can regulate diverse antigen-specific and spontaneous cytotoxic functions in vitro, suggesting that circulating granulocytes may have the potential for in vivo regulation of these cytotoxic effectors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871101

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  98 in total

1.  Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy.

Authors:  Shun-Jun Fu; Shun-Li Shen; Shao-Qiang Li; Yun-Peng Hua; Wen-Jie Hu; Li-Jian Liang; Bao-Gang Peng
Journal:  Med Oncol       Date:  2013-09-13       Impact factor: 3.064

2.  Prognostic significance of the ratio of absolute neutrophil to lymphocyte counts for breast cancer patients with ER/PR-positivity and HER2-negativity in neoadjuvant setting.

Authors:  Young Wha Koh; Hee Jin Lee; Jin-Hee Ahn; Jong Won Lee; Gyungyub Gong
Journal:  Tumour Biol       Date:  2014-07-02

3.  Elevated preoperative neutrophil-to-lymphocytes ratio predicts poor prognosis after esophagectomy in T1 esophageal cancer.

Authors:  Kenichi Nakamura; Naoya Yoshida; Yoshifumi Baba; Keisuke Kosumi; Tomoyuki Uchihara; Yuki Kiyozumi; Mayuko Ohuchi; Takatsugu Ishimoto; Masaaki Iwatsuki; Yasuo Sakamoto; Masayuki Watanabe; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2017-01-17       Impact factor: 3.402

4.  Post-treatment neutrophil-to-lymphocyte ratio predicts for overall survival in brain metastases treated with stereotactic radiosurgery.

Authors:  Mudit Chowdhary; Jeffrey M Switchenko; Robert H Press; Jaymin Jhaveri; Zachary S Buchwald; Philip A Blumenfeld; Gaurav Marwaha; Aidnag Diaz; Dian Wang; Ross A Abrams; Jeffrey J Olson; Hui-Kuo G Shu; Walter J Curran; Kirtesh R Patel
Journal:  J Neurooncol       Date:  2018-05-30       Impact factor: 4.130

5.  Neutrophil/lymphocyte ratio predicts the prognosis in esophageal squamous cell carcinoma patients.

Authors:  Keisuke Kosumi; Yoshifumi Baba; Takatsugu Ishimoto; Kazuto Harada; Kenichi Nakamura; Mayuko Ohuchi; Yuki Kiyozumi; Daisuke Izumi; Ryuma Tokunaga; Katsunobu Taki; Takaaki Higashi; Tatsunori Miyata; Junji Kurashige; Yukiharu Hiyoshi; Shiro Iwagami; Yasuo Sakamoto; Yuji Miyamoto; Naoya Yoshida; Masayuki Watanabe; Hideo Baba
Journal:  Surg Today       Date:  2015-06-03       Impact factor: 2.549

6.  Clinical Parameters for Predicting the Survival in Patients with Squamous and Non-squamous-cell NSCLC Receiving PD-1 Inhibitor Therapy.

Authors:  Minehiko Inomata; Takahiro Hirai; Zenta Seto; Kotaro Tokui; Chihiro Taka; Seisuke Okazawa; Kenta Kambara; Tomomi Ichikawa; Shingo Imanishi; Toru Yamada; Toshiro Miwa; Ryuji Hayashi; Kazuyuki Tobe
Journal:  Pathol Oncol Res       Date:  2018-09-19       Impact factor: 3.201

7.  Immunological markers predict the prognosis of patients with squamous non-small cell lung cancer.

Authors:  Long Jiang; Zerui Zhao; Shanshan Jiang; Yongbin Lin; Han Yang; Zehua Xie; Yaobin Lin; Hao Long
Journal:  Immunol Res       Date:  2015-07       Impact factor: 2.829

8.  Standardized pretreatment inflammatory laboratory markers and calculated ratios in patients with oral squamous cell carcinoma.

Authors:  Martin Grimm; Johan Rieth; Sebastian Hoefert; Michael Krimmel; Sven Rieth; Peter Teriete; Susanne Kluba; Thorsten Biegner; Adelheid Munz; Siegmar Reinert
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-29       Impact factor: 2.503

9.  The neutrophil/lymphocyte ratio is an independent prognostic indicator in patients with bone metastasis.

Authors:  Shouyu Wang; Zhen Zhang; Fengqi Fang; Xue Gao; Wei Sun; Huanran Liu
Journal:  Oncol Lett       Date:  2011-05-13       Impact factor: 2.967

10.  Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression.

Authors:  Mairéad G McNamara; Zarnie Lwin; Haiyan Jiang; Arnoud J Templeton; Gelareh Zadeh; Mark Bernstein; Caroline Chung; Barbara-Ann Millar; Normand Laperriere; Warren P Mason
Journal:  J Neurooncol       Date:  2014-01-28       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.